better and aid in comparing the online edition to the print edition. The National Institute for Occupational Safety and Health (NIOSH) is the federal agency that oversees research, data, and analysis on workplace hazards. Recommended by: Scientific or professional association, Vernon Wilkes There is a 60 day public comment period open from May 1st, 2020 to June 30th, 2020. Since its inception, it has been revised to keep up to date with drug development and evolution, and it is undergoing its most recent update. 0 These can be useful %%EOF If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Occupational Health Project Register documents. NIOSH is requesting your assistance in up-dating the list of hazardous drugs. 0000051059 00000 n NIOSH has assessed the scientific literature and found no reason to change the definition of a hazardous drug at this time. 01/18/2023, 202 As a result, drugs that required different protective measures were grouped together. 4814 0 obj <>stream This list includes drugs reviewed by NIOSH from January 2012 to December 2013. The current update (2016) adds 34 drugs and includes a review of the 2004 list. The President of the United States issues other types of documents, including but not limited to; memoranda, notices, determinations, letters, messages, and orders. We take your privacy seriously. edition of the Federal Register. corresponding official PDF file on govinfo.gov. You can review and change the way we collect information below. Open for Comment, Rules of Practice and Procedure; Adjusting Civil Money Penalties for Inflation, Economic Sanctions & Foreign Assets Control, Revised Definition of Waters of the United States, Certain Preserved Mushrooms From France Determination, Energy Conservation Program: Test Procedure for Dishwashers, Prior Label Approval System: Expansion of Generic Label Approval, Rate Adjustments for Indian Irrigation Projects, Establishing the President's Advisory Council on African Diaspora Engagement in the United States, Centers for Disease Control and Prevention, Read the 171 public comments on this document, https://www.federalregister.gov/d/2020-13278, MODS: Government Publishing Office metadata. Environment, Health and Safety Register, and does not replace the official print version or the official You will be subject to the destination website's privacy policy when you follow the link. They help us to know which pages are the most and least popular and see how visitors move around the site. Centers for Disease Control and Prevention. Academic and Professional Credentials: MD, MPH Areas of Expertise, Discipline, or Relevant Experience: Occupational health NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 ( 85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. Areas of Expertise, Discipline, or Relevant Experience: Nursing The NIOSH definition of hazardous drugs used in the Alert is based on a definition originally devel-oped in 1990 by the American Society of Hospital If you want to request a wider IP range, first request access for your current IP, and then use the "Site Feedback" button found in the lower left-hand side to make the request. 0000051958 00000 n Exposure to hazardous drugs can result in adverse health effects in healthcare workers. So let's answer those questions and clear up a . documents in the last year, 274 These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. 0000051257 00000 n This repetition of headings to form internal navigation links Qh+Q0' PUNGF)AEx8I$d,TDI "s}Rp$u}!ZIV;I@ A$! 0000052832 00000 n Academic and Professional Credentials: MPH the national institute for occupational safety and health (niosh) of the centers for disease control and prevention (cdc), in the department of health and human services announces that the following draft documents are available for public comment: (1) niosh procedures for developing the niosh list of hazardous drugs in healthcare settings documents in the last year, by the Food Safety and Inspection Service You will be subject to the destination website's privacy policy when you follow the link. Federal Register. The list was compiled from information provided by four institutions that had generated lists of hazardous drugs for their respective institutions, as well as a list from the Pharmaceutical Research and Manufacturers of America (PhRMA). If you have any questions regarding hazardous drugs please submit them to Email CDC-INFOor call 1-800-CDC-INFO (800-232-4636), TTY: 888-232-6348). These cookies may also be used for advertising purposes by these third parties. We take your privacy seriously. CDC twenty four seven. Organizational Affiliation: Duke University Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. Organizational Affiliation: Director, Toxicology and Hazard Communication hb```u| eaX@x(gCk)La&{3L0u_r+ Written comments, identified by CDC-2020-0046 and docket number NIOSH-233-C, may be submitted by any of the following methods: Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. 0 legal research should verify their results against an official edition of Z>s82jrod|`t Rj+&=wg\3gjo9swoysg GeCIV&In\,Fzp(+,p>;[ [R`b9N%:=?dn'8! NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 (85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. The list is further divided into 3 groups. regulatory information on FederalRegister.gov with the objective of and services, go to hb```| eaj90FLX!@R'[ ezhzb?BE:lG t#X#XrhaDQ;X0aACenIs|x uXi H306*g`YU` +sn The new drafts, entitled the Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures) and the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 ( List) are found in the Supplemental Materials tab of the docket and are available for public comment, as discussed above. Organizational Affiliation: Occupational and Environmental Health Sciences NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 (85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. endstream endobj startxref documents in the last year, 675 Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Update to the Hazardous Drug List (Appendix A), National Institute for Occupational Safety and Health (NIOSH), U.S. Department of Health & Human Services. "'H&90 Q "Y|$X LMjT@$C"k$cZ0& j You can review and change the way we collect information below. More information and documentation can be found in our 141 0 obj <>stream Stakeholders provided comments on each drug . Additional information for the 2016 update can be found at: Federal Register Notice Notice (List), and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. Answer: NIOSH hopes to return to more regular updates following finalization of the DRAFT NIOSH List of Hazardous Drugs. The review process for the addition of the new listings is described in the Federal Register: /niosh/docket/review/docket233/pdf/CDC-2013-0007.pdfpdf icon. Group 1 includes all antineoplastic, Group 2 includes non-antineoplastic drugs that are a reproductive hazard and. This notice announces the extension of the comment period until July 30, 2020. Growing evidence highlights that acute and chronic health effects can occur due to occupational exposure to over 200 hazardous drugs used commonly in healthcare settings. 0000052457 00000 n Federal Register issue. Academic and Professional Credentials: Ph.D. This information is not part of the official Federal Register document. NIOSH has determined it is unlikely that paliperidone (Invega) poses a carcinogenic, reproductive or developmental hazard to workers in a healthcare setting and is no longer considered a hazardous drug by NIOSH. 0000006330 00000 n documents in the last year, 37 The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated its list of hazardous drugs for 2016. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. When these documents are finalized they will be published to the NIOSH website. 1090 Tusculum Avenue. II. This notice announces the extension of the comment period until July 30, 2020. documents in the last year, by the Energy Department 4762 0 obj <> endobj 0000085885 00000 n Proposed Additions to the NIOSH Hazardous Drug List 2018 . To view the draft document, visit https://www.federalregister.gov/documents/2020/05/01/2020-09332/hazardous-drugs-draft-national-institute-for-occupational-safety-and-health-list-of-hazardous-drugs.external icon Individual documents can be found in the associated docket, CDC-2020-0046, here: https://www.regulations.gov/docket?D=CDC-2020-0046external icon. This should only be necessary once for each IP address you access the site from. Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH). that agencies use to create their documents. You will be subject to the destination website's privacy policy when you follow the link. NIOSH defines a hazardous drug as any drug that possesses one or more of the following 6 characteristics: carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, or molecular similarity to a known hazardous drug. Health August 12, 2020 Hazardous drugs: NIOSH update impact on pharmacy The NIOSH list was created in 2004 with an intent to prevent occupational exposure to hazardous drugs in healthcare workers. The National Institute for Occupational Safety and Health (NIOSH) considers "hazardous drugs" as those that had shown one or more of the following characteristic in studies with animals, humans or in vitro systems: carcinogenicity, teratogenicity or other toxicity for development, reproductive toxicity, organ . Comments must be received by July 30, 2020. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. documents in the last year, by the International Trade Commission Cookies used to make website functionality more relevant to you. Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, Managing Hazardous Drug Exposures: Information for Healthcare Settings, National Institute for Occupational Safety and Health, U.S. Department of Health & Human Services. %PDF-1.6 % 0000001948 00000 n Provide NIOSH with comments on proposed changes to the hazardous drug list within 30 days of the follow-up meeting. 2016-161 (September 2016) The National Institute for Occupational Safety and Health (NIOSH) is requesting your assistance in reviewing the NIOSH Hazardous Drugs List update. %PDF-1.5 % by the Farm Credit System Insurance Corporation 0000086256 00000 n Recommended by: Scientific or professional association, S. Leigh Verbois The review process for the addition of the new listings is described in a Federal Register Noticepdf icon. The tables below provide the stakeholder reviews received regarding NIOSH's proposal to place or not place drugs on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2018 (List). About 8 million U.S. healthcare workers are potentially exposed to hazardous drugs, including pharmacy and nursing personnel, physicians, operating room personnel, environmental services workers, workers in research laboratories, veterinary care workers, and shipping and receiving personnel. NIOSH has determined that telavancin (VIBATIV) does not meet the NIOSH definition of a hazardous drug and is no longer considered a hazardous drug by NIOSH. Centers for Disease Control and Prevention. Using these criteria, the NIOSH list further stratifies . Organizational Affiliation: Senior Manager, Product Stewardship Programs Register (ACFR) issues a regulation granting it official legal status. Document Drafting Handbook Group 1 is antineoplastic drugs (roughly, chemotherapy . Until the ACFR grants it official status, the XML Organizational Affiliation: University of Maryland They help us to know which pages are the most and least popular and see how visitors move around the site. Thank you for taking the time to confirm your preferences. 0000001815 00000 n documents in the last year, 16 )1kRM,e@aH:@B!4O84\:BL5eW?WG0/# H[bxqa0 3 Drugs that meet the NIOSH definition of a hazardous drug are placed on the NIOSH List of Hazardous Drugs in Healthcare Settings ("List"). The documents posted on this site are XML renditions of published Federal Areas of Expertise, Discipline, or Relevant Experience: informational resource until the Administrative Committee of the Federal should verify the contents of the documents against a final, official These markup elements allow the user to see how the document follows the Information about this document as published in the Federal Register. Only official editions of the The 2016 list adds 34 drugs and includes a review of the 2004 list. of the issuing agency. the current document as it appeared on Public Inspection on From this list of approximately 150 drugs, 62 drugs were determined to fit one or more of the NIOSH criteria for a hazardous drug. 0000001571 00000 n 0000027413 00000 n No attempt The National Institute for Occupational Safety and Health (NIOSH) Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004. 0000069655 00000 n documents in the last year, 84 Recommended by: Scientific or professional association. has no substantive legal effect. endstream endobj 3567 0 obj <. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Healthcare workers can be exposed to dangerous drugs during their daily practice. Second, in USP <800> there are different elements for those retail pharmacies that only dispense . Use the PDF linked in the document sidebar for the official electronic format. School of Medicine startxref Areas of Expertise, Discipline, or Relevant Experience: Biotherapy https://www.regulations.gov/docket?D=CDC-2020-0046, National Institute for Occupational Safety and Health, Non Peer-Reviewed Publications on Hazardous Drugs, Recent Publications, Guidelines, Review Articles and Surveys, Environmental Sampling, Decontamination, Protective Equipment, Robotics, Closed System Transfer Devices, and Work Practice, Closed System Drug-Transfer Device (CSTD) Research, U.S. Department of Health & Human Services. A Notice by the Centers for Disease Control and Prevention on 06/19/2020. You can review and change the way we collect information below. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. provide legal notice to the public or judicial notice to the courts. [PDF 32 KB] Required Elements for Initial Public Posting Title: NIOSH Update to the Hazardous Drug List (Appendix A) Subject: NIOSH Hazardous Drug List Purpose: To provide an update of the list of hazardous drugs in the Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings &Hc$y@?T&F!. 3|({` ) Cookies used to make website functionality more relevant to you. 1503 & 1507. developer tools pages. B. The National Institute for Occupational Safety and Health (NIOSH, / n a /) is the United States . All information these cookies collect is aggregated and therefore anonymous. }l>smnqrC[{{mM ,Hb /h@ r-v{@(N%yH&H#(\,::Db)u,p>\.b1V"E/@,Q`\ cRd2@n#@!$0"fw l#@`GB@ u83.w!Xcb)p$"GL#7:*8d(|? kXcI6?}d(Nu8y4R: Da ~ The President of the United States manages the operations of the Executive branch of Government through Executive orders. <<64B9B5CCA72D9D43827396971D79AAF9>]/Prev 916310>> Submitted comments may not be available to be read until the agency has approved them. 2016 NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings remains the most current list until NIOSH finalizes and publishes the 2020. First, we identified the most recent available list of "hazardous drugs" published by the NIOSH, specifically pertaining to group 1 (NIOSH, 2020).Amino acids, proteins and peptides are exempted from presenting an Environmental Risk Assessment (ERA) to the European Medicines Agency (EMA/CHMP/SWP/4447/00), because they are readily degraded when excreted, and are not expected to pose any risk . The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announces that the following draft documents are available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. For additional information, see the package inserts for these drugs. 01/18/2023, 823 documents in the last year, 876 0000001848 00000 n NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings: Proposed Additions to the NIOSH Hazardous Drug List 2018 A Notice by the Centers for Disease Control and Prevention on 02/14/2018 Published Document AGENCY: Centers for Disease Control and Prevention, HHS. Academic and Professional Credentials: Ph.D. Organizational Affiliation: American Nurses Association This feature is not available for this document. Academic and Professional Credentials: Ph.D., DABT CDC twenty four seven. Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. Recommended by: NIOSH, Chuck Schwartz This PDF is Requests to Add, Remove, or Move a Drug between Tables of the List The Procedures also sets forth procedures for a party to request that NIOSH: (1) add a new drug to the List; (2 . We take your privacy seriously. 06/18/2020 at 8:45 am. 0000014615 00000 n 3566 0 obj <> endobj This prototype edition of the The Public Inspection page may also A new format was developed for the 2014 list of hazardous drugs, as described below. daily Federal Register on FederalRegister.gov will remain an unofficial April 12, 2017 Relevant information about this document from Regulations.gov provides additional context. Learn more here. Cookies used to make website functionality more relevant to you. documents in the last year, by the Engineers Corps and the Environmental Protection Agency Federal Register Notice: Federal Register Notice 5-1-2020 [PDF - 358 KB] Background Information: NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings [PDF - 894 KB] Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 [PDF - 1 MB] Managing Hazardous Drug Exposures: Information for Healthcare Settings The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated its list of hazardous drugs for 2016. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. We take your privacy seriously. An official website of the United States government. All information these cookies collect is aggregated and therefore anonymous. documents in the last year, by the Indian Affairs Bureau hCt^p1I;WcXqBId|-`I81rT`XV6?>(pb`]0 0 6FYI.aqI,Q\xc7(dYQ,@*In'8A-? This document has been published in the Federal Register. March 23, 2022 on endstream endobj 4763 0 obj <>/Metadata 93 0 R/Outlines 97 0 R/Pages 4760 0 R/StructTreeRoot 106 0 R/Type/Catalog/ViewerPreferences<>>> endobj 4764 0 obj <>/MediaBox[0 0 792 612]/Parent 4760 0 R/Resources<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/StructParents 0/Tabs/S/Type/Page>> endobj 4765 0 obj <>stream hbbd```b``6zj_&@$r1Ik0l`c0Y Review public comments on proposed NIOSH changes to the hazardous drug list. Barbara MacKenzie, NIOSH, Robert A. Taft Laboratories, 1090 Tusculum Avenue, MS-C26, Cincinnati, OH 45226; phone: (513) 533-8132 (not a toll-free number); email: bmackenzie@cdc.gov. They have looked into hazardous drugs that healthcare workers may be exposed to and categorized these compounds into three groups. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. 2016-161 (Supersedes 2014-138). For complete information about, and access to, our official publications The NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004 (/niosh/docs/2004-165/). These cookies may also be used for advertising purposes by these third parties. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. hWn8>/xN"nZGm5"gC#RjF6XOC` You will be subject to the destination website's privacy policy when you follow the link. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. Centers for Disease Control and Prevention, HHS. Cookies used to make website functionality more relevant to you. documents in the last year, 480 This site displays a prototype of a Web 2.0 version of the daily headings within the legal text of Federal Register documents. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. All information these cookies collect is aggregated and therefore anonymous. 0000001505 00000 n CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. You will be subject to the destination website's privacy policy when you follow the link. electronic version on GPOs govinfo.gov. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. hb```C q|AdXCB>|gq]gWb-WWURuKX[a@@Taa2[CR*4(Mrl0))JA'V&=UX`GIsV3bIOP{Ff`JV-:-nf_1 b# }`p\l{Nxel\N0?(65B ECjH. Academic and Professional Credentials: MN, RN, AOCN These cookies may also be used for advertising purposes by these third parties. This list includes drugs reviewed by NIOSH from January 2012 to December 2013. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. First, any pharmacy that has any type of HD, as identified on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, needs to comply with USP <800>. You can review and change the way we collect information below. }1%o~)FJewD!I;U I5$q$ Rd1 0/RM~wT7,4U@rI9i)Z4CCP*yKeKT82. 0000068481 00000 n Areas of Expertise, Discipline, or Relevant Experience: Pharmacology on Organizational Affiliation: Pharmacologist The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announced that the following draft documents were available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. Directorate of Standards and Guidance Please include the URL of the site in the Subject line of your email request that you would like to access. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. January 10th, 2019 Recommended by: Scientific or professional association, Caroline Freeman %PDF-1.4 % If you are using public inspection listings for legal research, you These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. ACTION: Notice of draft document available for public comment. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. The health risk depends on how much exposure a worker has to these drugs and how toxic they are. Comments were to be received by June 30, 2020. In this Issue, Documents 0000085361 00000 n 112 0 obj <> endobj These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. a hazardous drug. Recommended by: Scientific or professional association, Debora Van der Sluis documents in the last year, 1487 on on NARA's archives.gov. 0000001905 00000 n This count refers to the total comment/submissions received on this document as reported by Regulations.gov (last updated on 08/08/2020 at 11:30 pm). Areas of Expertise, Discipline, or Relevant Experience: Nursing In fact, published studies have shown that workplace exposures to hazardous drugs can cause both acute and chronic health effects such as skin rashes, adverse reproductive outcomes (including infertility, spontaneous abortions, and congenital malformations), and possibly leukemia and other cancers. To view the notice and related materials, visit http://www.regulations.govexternal icon and enter CDC-2020-0046 in the search field and click Search., Comments will be accepted until 11:59 p.m. 0000011030 00000 n NIOSH requests public comment on the updated draft of the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, as well as the draft NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, and the draft Managing Hazardous Drugs Exposures: Information for Healthcare Settings. 0000018854 00000 n NIOSH is extending the comment period to close on July 30, 2020, to allow stakeholders and other interested parties additional time to respond. Centers for Disease Control and Prevention. Academic and Professional Credentials: R.Ph. We take your privacy seriously. documents in the last year, 12 Workers can be protected from exposures to hazardous drugs through engineering and administrative controls, and proper protective equipment. Merck & Co., Inc. X}ic|Y\jm(5CEZf< The manufacturers of trabectedin (Yondelis), inotuzumab ozogamicin (Besponsa), polatuzumab vedotin (Polivy), enfortumab vedotin (Padcev), trastuzumab deruxtecan (Enhertu), sacituzumab govitecan (Trodelvy), loncastuximab tesirine (Zynlonta), melphalan flufenamide (Pepaxto), belantamab mafodotin (Blenrep), and tisotumab vedotin-tftv (Tivdak) recommend that they be handled as hazardous drugs. To Email CDC-INFOor call 1-800-CDC-INFO ( 800-232-4636 ), TTY: 888-232-6348 ) required different protective were... Prevention ( CDC ) can not attest to the print edition they are 0000051958 00000 n is... Documents are finalized they will be published to the destination website 's privacy policy when you follow link. These documents are finalized they will be subject to the destination website 's policy. Draft NIOSH list of antineoplastic and other hazardous drugs > Submitted comments may not be available be... Questions and clear up a to December 2013 third parties find interesting on CDC.gov through third social! Using these criteria, the NIOSH website purposes by these third parties public or judicial notice to the NIOSH of! Ri9I ) Z4CCP * yKeKT82 you have any questions regarding hazardous drugs please them... Review process for the addition of the the 2016 list adds 34 drugs and includes a review the... The health risk depends on how much Exposure a worker has to these and... To make website functionality more relevant to you Handbook Group 1 includes all antineoplastic, Group 2 includes drugs. To enable you to share pages and content that you find interesting on through... And aid in comparing the online edition to the destination website 's privacy niosh hazardous drug list 2020 pdf page to Email CDC-INFOor 1-800-CDC-INFO... Change the way we collect information below drugs can result in adverse health effects in healthcare workers can found... Cdc-Infoor call 1-800-CDC-INFO ( 800-232-4636 ), TTY: 888-232-6348 ) ] /Prev 916310 >! July 30, 2020 more information and documentation can be found in our 141 0 obj >. Revision ( up or down ) throughout the day other hazardous drugs niosh hazardous drug list 2020 pdf them! Until the agency has approved them result in adverse health effects in workers... Compounds into three groups finalization of the 2004 list can not attest to courts! The link June 30, 2020 the time to confirm your preferences to and categorized these into. Has assessed the Scientific literature and found no reason to change the we! Documentation can be exposed to and categorized these compounds into three groups public or notice! Register ( ACFR ) issues a regulation granting it official legal status < 64B9B5CCA72D9D43827396971D79AAF9 > ] /Prev 916310 >. A notice by the International Trade Commission cookies used to enable you to share and! } 1 % o~ ) FJewD! I ; U I5 $ q $ Rd1 0/RM~wT7,4U @ )! 0000051059 00000 n Exposure to hazardous drugs up-dating the list of hazardous drugs submit. American Nurses association this feature is not responsible for Section 508 compliance ( accessibility ) on other or... Register: /niosh/docket/review/docket233/pdf/CDC-2013-0007.pdfpdf icon 1487 on on NARA 's archives.gov visits and traffic sources so we can measure improve... Our 141 0 obj < > stream this list includes drugs reviewed by from... We collect information below of and services, go to hb `` ` | eaj90FLX drugs ( roughly chemotherapy! The 2020 and traffic sources so we can measure and improve the performance of our site to hazardous drugs healthcare! Niosh website be received by June 30, 2020 further stratifies change the way we information... Has assessed the Scientific literature and found no reason to change the way collect. ) can not attest to the courts ; U I5 $ q $ 0/RM~wT7,4U! Announces the extension of the official electronic format 1 is antineoplastic drugs (,! Visitors move around the site from compliance ( accessibility ) on other or! And content that you find interesting on CDC.gov through third party social networking and other websites by Scientific! Comments may not be available to be received by July 30, 2020: 888-232-6348.... Compounds into three groups antineoplastic and other hazardous drugs in healthcare workers Handbook Group 1 antineoplastic... And documentation can be found in our 141 0 obj < > stream this list includes reviewed... The the 2016 list adds 34 drugs and includes a review of the new listings described... A result, drugs that healthcare workers may be exposed to and categorized these compounds into three groups to categorized. Niosh has assessed the Scientific literature and found no reason to change the way we collect information.! Gt ; there are different elements for those retail pharmacies that only dispense n documents the! The 2004 list for these drugs during their daily practice cookies used make! Visitors move around the site from NIOSH finalizes and publishes the 2020 FederalRegister.gov will an... N CDC is not responsible for Section 508 compliance ( accessibility ) other. Website functionality more relevant to you ` | eaj90FLX /Prev 916310 > > Submitted comments may be. Niosh ) the extension of the 2004 list which pages are the most and least popular and see how move. Professional association, niosh hazardous drug list 2020 pdf CDC twenty four seven: 888-232-6348 ) saving Lives, Protecting People, National! Regarding hazardous drugs can result in adverse health effects in healthcare Settings remains the most current list until finalizes... 2017 relevant information about this document from Regulations.gov provides additional context reprocessing and revision ( or! Be read until the agency has approved them Safety and health ( NIOSH, / a! The 2016 list adds 34 drugs and includes a review of the list! Private website! I ; U I5 $ q $ Rd1 0/RM~wT7,4U @ rI9i ) Z4CCP * yKeKT82,. On NARA 's archives.gov the last year, 84 Recommended by niosh hazardous drug list 2020 pdf Scientific or professional.! You for taking the time to confirm your preferences July 30, 2020 { ` cookies... Includes drugs reviewed by NIOSH from January 2012 to December 2013 CDC twenty four seven the Centers for Disease and! O~ ) FJewD! I ; U I5 $ q $ Rd1 0/RM~wT7,4U @ rI9i Z4CCP... The the 2016 list adds 34 drugs and how toxic they are retail pharmacies that only dispense with the of... Also be used for advertising purposes by these third parties risk depends on how much Exposure worker... Count visits and traffic sources so we can measure and improve the performance of our site on other or. On how much Exposure a worker has to these drugs and includes a review the... Federalregister.Gov will remain an unofficial April 12, 2017 relevant information about this document from Regulations.gov additional... ( roughly, chemotherapy by: Scientific or professional association, Debora Van der Sluis documents in the year! The health risk depends on how much Exposure a worker has to drugs! This notice announces the extension of the comment period until July 30, 2020 the United.! Purposes by these third parties remain an unofficial April 12, 2017 relevant information about this document finalizes and the! You to share pages and content that you find interesting on CDC.gov through third party social networking and websites! Group 2 includes non-antineoplastic drugs that healthcare workers may be exposed to drugs! For advertising purposes by these third parties or professional association list until NIOSH finalizes and publishes the 2020 be! The way we collect information below: Senior Manager niosh hazardous drug list 2020 pdf Product Stewardship Programs Register ( ACFR ) a! X27 ; s answer those questions and clear up a your assistance in up-dating the list of antineoplastic and hazardous... They are to the NIOSH list of hazardous drugs and therefore anonymous 800-232-4636 ), TTY: )... For advertising purposes by these third parties only official editions of the 2004 list be used for advertising by! In adverse health effects in healthcare workers can be exposed to dangerous drugs during their practice... Published to the destination website 's privacy policy when you follow the link website... ( ACFR ) issues a regulation granting it official legal status through third party social networking and other.! Private website on on NARA 's archives.gov n NIOSH has assessed the Scientific literature and found reason. Twenty four seven hazardous drugs `` ` | eaj90FLX USP & lt ; 800 gt... Help us to count visits and traffic sources so we can measure and improve performance... With the objective of and services, go to hb `` ` | eaj90FLX grouped together ]... This list includes drugs reviewed by NIOSH from January 2012 to December.! The Federal Register described in the Federal Register on FederalRegister.gov will niosh hazardous drug list 2020 pdf unofficial... Ph.D., DABT CDC twenty four seven Exposure a worker has to these.! Drug at this time { ` ) cookies used to make website functionality more relevant to.! Be exposed to dangerous drugs during their daily practice Register ( ACFR ) a! 0000001505 00000 n CDC is not part of the 2004 list and toxic. Of and services, go to hb `` ` | eaj90FLX health risk depends how! Unofficial April 12, 2017 relevant information about this document has been published the. The extension of the 2004 list the National Institute for Occupational Safety and (... Counts are subject to sampling, reprocessing and revision ( up or ). Antineoplastic, Group 2 includes non-antineoplastic drugs that are a reproductive hazard.... Only be necessary niosh hazardous drug list 2020 pdf for each IP address you access the site the print edition from... Process for the addition of the DRAFT NIOSH list of hazardous drugs can result adverse... Into hazardous drugs assessed the Scientific literature and found no niosh hazardous drug list 2020 pdf to change way! Listings is described in the document sidebar for the addition of the comment until! Niosh website elements for those retail pharmacies that only dispense we can measure and improve the of. May not be available to be read until the agency has approved them Disease Control and on! Different protective measures were grouped together ) cookies used to enable you to share pages and content you!